A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
Clinical trial NCT05402111 · COMPLETED
Trial details
- NCT number
- NCT05402111
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2023-09-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.